Fundación Para La Investigación Del Hospital Clínico De Valencia
Clinical trials sponsored by Fundación Para La Investigación Del Hospital Clínico De Valencia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can 3D models outperform CT scans in judging pancreatic tumor shrinkage? Results expected Nov 2026 (estimated)
- Can a diabetes drug help dialysis patients with severe heart failure shed salt? Results expected Dec 2026 (estimated)
- Potassium binder may unlock lifesaving heart drugs for seniors Results expected Dec 2026 (estimated)
- Blood test could guide stronger chemo for colon cancer Results expected Jan 2027 (estimated)
- Three ways to trigger ovulation: which yields more mature eggs in Low-Reserve IVF? Results expected Jul 2027 (estimated)
-
Gene-Guided diabetes care shows promise in new trial
Disease control CompletedThis study tests whether choosing diabetes medications based on a person's genetic profile helps control blood sugar better than standard treatment. About 500 adults with type 2 diabetes that is not well controlled will be randomly assigned to either gene-guided or standard care.…
Phase 4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Leg wraps may help heart failure patients shed fluid faster
Symptom relief CompletedThis study tested whether adding leg compression to standard diuretic treatment helps people hospitalized with heart failure and severe fluid buildup. 106 adults received either diuretics alone or diuretics plus leg compression for up to 72 hours. Researchers measured changes in …
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Beyond the breath test: a deeper look at lung health in smokers
Knowledge-focused CompletedThis study follows 236 smokers or ex-smokers who have respiratory symptoms but normal spirometry, a standard test for COPD. Researchers measure a different lung function called DLCO, which checks how well oxygen moves from the lungs into the blood. Participants are split into two…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC